Financials

News Discussions Technicals Seasonals

ONCOZ fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

OncoZenge AB operates as a pharmaceutical company. The firm offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The compay was founded on June 15, 2020 and is headquartered in Bromma, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ONCOZ has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company